Chemical permeation enhancement

Enhancement in Drug Delivery

Volumn , Issue , 2006, Pages 233-254

  Williams, Adrian C ^a   Barry, Brian W ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056964688     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (85)

1. Barry, B.W. 1983. Dermatological formulations percutaneous absorption. New York: Marcel Dekker.
2. Williams, A.C. 2003. Transdermal and topical drug delivery: From theory to clinical practice. London: Pharmaceutical Press.
3. Bucks, D., and H.I. Maibach. 1999. Occlusion does not uniformly enhance penetration in vivo. In Percutaneous absorption: Drugs, cosmetics, mechanisms, and methodology, 3rd ed., eds. R.L. Bronaugh and H.I. Maibach. New York: Marcel Dekker, chap. 4.
4. Walkley, K. 1972. Bound water in stratum corneum measured by differential scanning calorimetry. J Invest Dermatol 59:225.
5. Cornwell, P.A., et al. 1994. Wide-angle x-ray diffraction of human stratum corneum: Effects of hydration and terpene enhancer treatment. J Pharm Pharmacol 46:938.
6. Van Hal, D.A., et al. 1996. Structure of fully hydrated human stratum corneum: A freeze fracture electron microscopy study. J Invest Dermatol 106:89.
7. Menon, G.K., and P.M. Elias. 1997. Morphological basis for a pore-pathway in mammalian stratum corneum. Skin Pharmacol 10:235.
8. Bond, J.R., and B.W. Barry. 1986. Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: Hydration damage. J Invest Dermatol 90:486.
9. Kligman, A.M. 1965. Topical pharmacology and toxicology of dimethylsulfoxide. JAMA 193:796.
10. Southwell, D., and B.W. Barry. 1983. Penetration enhancers for human skin: Mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols and caffeine. J Invest Dermatol 80:507.
11. Barry, B.W., D. Southwell, and R. Woodford. 1984. Optimisation of bioavailability of topical steroids: Penetration enhancers under occlusion. J Invest Dermatol 82:49.
12. Bennett, S.L., B.W. Barry, and R. Woodford. 1984. Optimisation of bioavailability of topical steroids: Non-occluded penetration enhancers under thermodynamic control. J Pharm Pharmacol 37:298.
13. Oertel, R.P. 1997. Protein conformational changes induced in human stratum corneum by organic sulphoxides: An infrared spectroscopic investigation. Biopolymer 16:2329.
14. Anigbogu, A.N.C., et al. 1995. Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethylsulphoxide and human stratum corneum. Int J Pharm 125:265.
15. Hoogstraate, A.J., et al. 1991. Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones. Int J Pharm 76:37.
16. Pilgram, G.S.K., et al. 2001. The influence of two azones and sebaceous lipids on the lateral organization of lipids isolated from human stratum corneum. Biochim Biophys Acta Biomembr 1511:244.
17. Wiechers, J.W. 1989. Absorption, distribution, metabolism, and excretion of the cutaneous penetration enhancer azone. PhD thesis, University of Groningen.
18. Wiechers, J.W., and R.A. de Zeeuw. 1990. Transdermal drug delivery: Efficacy and potential applications of the penetration enhancer azone. Drug Design Del 6:87.
19. Afouna, M.I., et al. 2003. Effect of azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice. Int J Pharm 253:159.
20. Park, E.S., et al. 2001. Effects of adhesives and permeation enhancers on the skin permeation of captopril. Drug Dev Ind Pharm 27:975.
21. Jungbauer, F.H.W., P.J. Coenraads, and S.H. Kardaun. 2001. Toxic hygroscopic contact reaction to N-methyl-2-pyrrolidone. Contact Dermatitis 45:303.
22. Aungst, B.J., N.J. Rogers, and E. Shefter. 1986. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm 33:2256.
23. Aungst, B.J. 1989. Structure-effects studies of fatty acid isomers as skin penetration enhancers and skin irritants. Pharm Res 6:244.
24. Funke, A.P., et al. 2002. Transdermal delivery of highly lipophilic drugs: In vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations. Pharm Res 19:661.
25. Santoyo, S., and P. Ygartua. 2000. Effect of skin pre-treatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application. Eur J Pharm Biopharm 50:245.
26. Goodman, M., and B.W. Barry. 1989. Lipid-protein-partitioning theory (LPP) theory of skin enhancer activity: Finite dose technique. Int J Pharm 57:29.
27. Aboofazeli, R., H. Zia, and T.E. Needham. 2002. Transdermal delivery of nicardipine: An approach to in vitro permeation enhancement. Drug Del 9:239.
28. Takahashi, K., et al. 2002. Effect of fatty acid diesters on permeation of anti-inflammatory drugs through rat skin. Drug Dev Ind Pharm 28:1285.
29. Ongpipattanakul, B., et al. 1991. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res 7:350.
30. Tanojo, H., et al. 1997. In vitro human skin barrier perturbation by oleic acid: Thermal analysis and freeze fracture electron microscopy studies. Thermochim Acta 293:77.
31. Berner, B., et al. 1989. Ethanol: Water mutually enhanced transdermal therapeutic system II: Skin permeation of ethanol and nitroglycerin. J Pharm Sci 78:402.
32. Friend, D., et al. 1988. Transdermal delivery of levonorgestrel. I. Alkanols as permeation enhancers. J Control Release 7:243.
33. Pershing, L.K., L.D. Lambert, and K. Knutson. 1990. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm Res 7:170.
34. Kurihara-Bergstrom, T., et al. 1990. Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin. Pharm Res 7:762.
35. Megrab, N.A., A.C. Williams, and B.W. Barry. 1995. Oestradiol permeation across human skin, silastic and snakeskin membranes: The effects of ethanol/water co-solvent systems. Int J Pharm 116:101.
36. Thomas, N.S., and R. Panchagnula. 2003. Transdermal delivery of zidovudine: Effect of vehicles on permeation across rat skin and their mechanism of action. Pharm Sci 18:71.
37. Morimoto, H., et al. 2002. In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol. Biol Pharm Bull 25:134.
38. Andega, S., N. Kanikkannan, and M. Singh. 2001. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J Control Release 77:17.
39. Tupker, R.A., J. Pinnagoda, and J.P. Nater. 1990. The transient and cumulative effect of sodium lauryl sulphate on the epidermal barrier assessed by transepidermal water loss: Inter-individual variation. Acta Derm Venereol (Stockh) 70:1.
40. Watkinson, A.C., et al. 1998. Skin penetration of a series of nonoxynol homologues. In Perspectives in percutaneous penetration, vol. 5b, eds. K.R. Brain, V.J. James, and K.S. Waters. Cardiff: STS Publishing Ltd.
41. Sarpotdar, P.P., and J.L. Zatz. 1986. Percutaneous absorption enhancement by non-ionic surfactants. Drug Dev Ind Pharm 12:1625.
42. Sarpotdar, P.P., and J.L. Zatz. 1986. Evaluation of penetration enhancement of lidocaine by non-ionic surfactants through hairless mouse skin in vitro. J Pharm Sci 75:176.
43. Yu, D., et al. 1988. Percutaneous absorption of nicardipine and ketorolac in rhesus monkeys. Pharm Res 5:457.
44. Rigg, P.C., and B.W. Barry. 1990. Shed snakeskin and hairless mouse skin as model membranes for human skin during permeation studies. J Invest Dermatol 94:235.
45. Gloor, M., et al. 2001. Clinical effect of salicylic acid and high dose urea applied in standardized NRF formulations. Pharmazie 56:810.
46. Wong, O., et al. 1989. Unsaturated cyclic ureas as new non-toxic biodegradable transdermal penetration enhancers. II. Evaluation study. Int J Pharm 52:191.
47. Williams, A.C., and B.W. Barry. 1989. Urea analogues in propylene glycol as penetration enhancers in human skin. Int J Pharm 56:43.
48. Williams, A.C., and B.W. Barry. 1989. Essential oils as novel human skin penetration enhancers. Int J Pharm 57:R7.
49. Williams, A.C., and B.W. Barry. 1991. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancers. Pharm Res 8:17.
50. Williams, A.C., and B.W. Barry. 1991. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int J Pharm 74:157.
51. Nagai, T., et al. 1989. Effect of limonene and related compounds on the percutaneous absorption of indomethacin, Proceedings of the 16th International Symposium on Controlled Release on Bioactive Materials, Chicago, USA, 181.
52. Okabe, H., et al. 1989. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Design Del 4:313.
53. Fang, J.Y., et al. 2003. Efficacy and irritancy of enhancers on the in vitro and in vivo percutaneous absorption of curcumin. J Pharm Pharmacol 55:593.
54. Barry, B.W., and A.C. Williams. 1989. Human skin penetration enhancement: The synergy of propylene glycol with terpenes, Proceedings of the 16th International Symposium on Controlled Release on Bioactive Materials, Chicago, USA, 33.
55. Vaddi, H.K., P.C. Ho, and S.Y. Chan. 2002. Terpenes in propylene glycol as skin-penetration enhancers: Permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci 91:1639.
56. Vaddi, H.K., et al. 2003. Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneum. Biol Pharm Bull 26:220.
57. Cornwell, P.A., and B.W. Barry. 1994. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J Pharm Pharmacol 46:261.
58. Kadir, R., and B.W. Barry. 1991. a-Bisabolol, a possible safe penetration enhancer for dermal and transdermal therapeutics. Int J Pharm 70:87.
59. Jain, A.K., N.S. Thomas, and R. Panchagnula. 2002. Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release 79:93.
60. El-Kattan, A.F., C.S. Asbill, and B.B. Michniak. 2000. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm 198:179.
61. Monti, D., et al. 2002. Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin. Int J Pharm 237:209.
62. Cal, K., S. Janicki, and M. Sznitowska. 2001. In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin. Int J Pharm 224:81.
63. Cornwell, P.A., et al. 1996. Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle x-ray diffraction and enhancer uptake studies. Int J Pharm 127:9.
64. Kato, A., Y. Ishibashi, and Y. Miyake. 1987. Effect of egg-yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 39:399.
65. Vavrova, K. 2003. Modification of the skin barrier properties. Penetration enhancers and the stratum corneum repair. PhD diss., Charles University in Prague.
66. Vavrova, K., et al. 2003. L -serine and glycine based ceramide analogues as transdermal permeation enhancers: Polar head size and hydrogen bonding. Bioorg Med Chem Lett 14:2351.
67. Vavrova, K., et al. 2003. Synthetic ceramide analogues as skin permeation enhancers: Structure- activity relationships. Bioorg Med Chem 24:5381.
68. Vavrova, K., et al. 2003. Synthesis and evaluation of the novel ceramide analogue based on L -serine for the skin barrier repair. J Invest Dermatol 5:1261.
69. Menon, G.K., and S.H. Lee. 1998. Ultrastructural effects of some solvents and vehicles on the stratum corneum and other skin components: Evidence for an extended mosaic-partitioning model of the skin barrier. In Dermal absorption and toxicity assessment, eds. M.S. Roberts and K.A. Walters. New York: Marcel Dekker, chap. 29.
70. Elias, P.M., et al. 2003. Metabolic approaches to transdermal drug delivery. In Transdermal drug delivery, 2nd ed., eds. R.H. Guy and J. Hadgraft. New York: Marcel Dekker, chap. 8.
71. Karande, P., A. Jain, and S. Mitragotri. 2004. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 22:192.
72. Gwak, H.S., I.S. Oh, and I.K. Chun. 2004. Transdermal delivery of ondansetron hydrochloride:Effects of vehicles and penetration enhancers. Drug Dev Ind Pharm 30:187.
73. Wagner, H., et al. 2004. Effects of various vehicles on the penetration of flufenamic acid into human skin. Eur J Pharm Biopharm 58:121.
74. Yamashita, F., and M. Hashida. 2003. Mechanistic and empirical modelling of skin permeation of drugs. Adv Drug Deliv Rev 55:1185.
75. Ghafourian, T., et al. 2004. The effect of penetration enhancers on drug delivery through skin:A QSAR study. J Control Release 99:113.
76. Warner, K.S., et al. 2003. Structure-activity relationship for chemical skin permeation enhancers:Probing the chemical microenvironment of the site of action. J Pharm Sci 92:1305.
77. He, N., et al. 2004. Mechanistic study of chemical skin permeation enhancers with different polar and lipophilic functional groups. J Pharm Sci 93:1415.
78. Caspers, P.J., et al. 2002. Monitoring the penetration enhancer dimethyl sulfoxide in human stratum corneum in vivo by confocal Raman spectroscopy. Pharm Res 19:1577.
79. Barry, B.W. 1991. Lipid-protein-partitioning theory of skin penetration enhancement. J Control Release 15:237.
80. Bouwstra, J.A., I. van den Bergh, and M. Suhonen. 2001. Topical application of drugs: Mechanisms involved in chemical enhancement. J Recept Signal Transduct Res 21:259.
81. Purdon, C.H., et al. 2004. Penetration enhancement of transdermal delivery-current permutations and limitations. Crit Rev Ther Drug Carrier Syst 21:97.
82. Ting, W.W., C.D. Vest, and R.D. Sontheimer. 2004. Review of traditional and novel modalities that enhance the permeability of local therapeutics. Int J Dermatol 43:538.
83. Barry, B.W. 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101.
84. Karande, P., et al. 2005. Design principles of chemical penetration enhancers for transdermal drug delivery. PNAS 102:4688.
85. Barry, B.W. 2004. Breaching the skin’s barrier to drugs. Nat Biotechnol 22:165.